Use of pertussis toxin as a therapeutic agent
US9801921B2 · kind B2 · utility
2Cited by
1References
14Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 29, 2012 |
| Grant date | Oct 31, 2017 |
| Priority date | — |
| Expiry date | Jun 29, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application relates to the use of a pertussis toxin, and its derivatives, analogs, salts and pharmaceutical equivalents. In one embodiment, the invention provides a method of treating an autoimmune disease by administering pertussis toxin to the individual. In another embodiment, the autoimmune disease is multiple sclerosis. In another embodiment, the invention provides a method of treating a neurodegenerative disease such as Alzheimer's disease or Parkinson's disease by administering pertussis toxin, or a derivative, analog, salt or pharmaceutical equivalent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.